spiraprilat has been researched along with timolol in 2 studies
| Studies (spiraprilat) | Trials (spiraprilat) | Recent Studies (post-2010) (spiraprilat) | Studies (timolol) | Trials (timolol) | Recent Studies (post-2010) (timolol) |
|---|---|---|---|---|---|
| 20 | 7 | 0 | 3,932 | 1,198 | 805 |
| Protein | Taxonomy | spiraprilat (IC50) | timolol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0003 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.0026 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 0.452 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.712 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.712 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cinotti, AA; Constad, WH; Fiore, P; Samson, C | 1 |
| Ahn, HS; Barnett, A; Baum, T; Cedeno, K; Smith, EM; Watkins, RW; Yuen, PH | 1 |
1 trial(s) available for spiraprilat and timolol
| Article | Year |
|---|---|
Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Phenylbutyrates; Pulse; Spiro Compounds; Time Factors; Timolol | 1988 |
1 other study(ies) available for spiraprilat and timolol
| Article | Year |
|---|---|
Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits.
Topics: Administration, Topical; Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry; Consciousness; Intraocular Pressure; Male; Phenylbutyrates; Rabbits; Spiro Compounds; Time Factors; Timolol | 1987 |